FindTrial
Sign In

Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial

Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial - Chloroquine and hydroxychloroquine for treatment of COVID-19: systematic review of randomized and non-randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000040188
Enrollment
Unknown
Registered
2020-04-17
Start date
2020-04-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

None listed

Sponsors

Yokohama City University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: COVID-19

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
All cause death (odds ratio). Viral clearance on day 7—

Countries

Japan,North America

Contacts

Public ContactNobuyuki Horita

Yokohama City University School of Medicine Department of Pulmonology

horitano@yokohama-cu.ac.jp0457872800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026